[go: up one dir, main page]

ZA971663B - Porcine reproductive and respiratory syndrome vaccine. - Google Patents

Porcine reproductive and respiratory syndrome vaccine.

Info

Publication number
ZA971663B
ZA971663B ZA9701663A ZA971663A ZA971663B ZA 971663 B ZA971663 B ZA 971663B ZA 9701663 A ZA9701663 A ZA 9701663A ZA 971663 A ZA971663 A ZA 971663A ZA 971663 B ZA971663 B ZA 971663B
Authority
ZA
South Africa
Prior art keywords
respiratory syndrome
porcine reproductive
syndrome vaccine
vaccine
porcine
Prior art date
Application number
ZA9701663A
Inventor
Richard A Hesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA971663(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA971663B publication Critical patent/ZA971663B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
ZA9701663A 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine. ZA971663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01

Publications (1)

Publication Number Publication Date
ZA971663B true ZA971663B (en) 1997-08-26

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701663A ZA971663B (en) 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine.

Country Status (19)

Country Link
EP (1) EP0894007A1 (en)
JP (1) JP3135069B2 (en)
KR (1) KR100297537B1 (en)
CN (1) CN1165342C (en)
AR (1) AR006023A1 (en)
AU (1) AU2277497A (en)
BG (1) BG64693B1 (en)
BR (1) BR9708443B1 (en)
CA (1) CA2248182C (en)
CO (1) CO4600644A1 (en)
CZ (1) CZ273798A3 (en)
EE (1) EE04741B1 (en)
HU (1) HUP9901958A3 (en)
MY (1) MY115070A (en)
PL (1) PL328627A1 (en)
RU (1) RU2187333C2 (en)
SK (1) SK119498A3 (en)
WO (1) WO1997031651A1 (en)
ZA (1) ZA971663B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2290220C (en) 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
PL204373B1 (en) 1999-03-08 2010-01-29 Boehringer Ingelheim Vetemendi Prrsv vaccines
JP4778620B2 (en) 1999-04-22 2011-09-21 ユナイテッド ステイツ デパートメント オブ アグリカルチャー Pig breeding / breathing disorder syndrome vaccine based on isolate JA-142
AU2005265142A1 (en) 2004-06-18 2006-01-26 Regents Of The University Of Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
ES2603553T3 (en) 2005-06-24 2017-02-28 Regents Of The University Of Minnesota PRRS viruses, infectious clones, mutants thereof, and methods of use
CN101612395B (en) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 Method for producing blue-ear disease vaccine by culturing sensitive cell
AR078253A1 (en) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed METHODS TO REDUCE ANTIVIRICAL ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH BETTER IMMUNOGENICITY
DK2959916T3 (en) 2011-02-17 2018-10-29 Boehringer Ingelheim Vetmedica Gmbh New European PRRSV strain.
PH12013501708B1 (en) 2011-02-17 2018-08-03 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR101300528B1 (en) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 Composition for prevention and treatment of Actinobacillus pleuropneumoniae infection
WO2014150822A2 (en) 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EP4012025A1 (en) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transport medium for samples containing nucleic acids and/or proteins
CZ309704B6 (en) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transport medium for virus transport and storage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
DE69206631T2 (en) * 1991-10-14 1996-05-15 Akzo Nobel Nv Pig reproductive and respiratory syndrome vaccine (PRRS) and diagnosis.
FR2686097B1 (en) * 1992-01-14 1994-12-30 Rhone Merieux PREPARATION OF ANTIGENS AND MYSTERY DISEASE VIRUS VACCINES, ANTIGENS AND VACCINES OBTAINED FOR THE PREVENTION OF THIS DISEASE.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
CZ289743B6 (en) * 1993-02-08 2002-03-13 Bayer Corporation Porcine reproductive and respiratory syndrome virus (PRRSV) isolate, process for growing PRRSV, tissue culture, process for preparing a vaccine and the vaccine containing the PRRSV isolate
ES2074950B1 (en) * 1993-09-17 1996-03-16 Iberica Cyanamid VACCINE FOR THE PREVENTION OF REPRODUCTIVE AND RESPIRATORY DISEASE OF THE SOW.
DE69522984T2 (en) * 1994-04-11 2002-04-25 Akzo Nobel Nv Pig reproductive respiratory syndrome virus vaccine European strains
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
BG102809A (en) 1999-05-31
PL328627A1 (en) 1999-02-15
JPH11506122A (en) 1999-06-02
MY115070A (en) 2003-03-31
AR006023A1 (en) 1999-07-21
JP3135069B2 (en) 2001-02-13
RU2187333C2 (en) 2002-08-20
KR100297537B1 (en) 2001-10-26
CZ273798A3 (en) 1999-02-17
CN1216922A (en) 1999-05-19
EE04741B1 (en) 2006-12-15
HUP9901958A2 (en) 1999-10-28
HUP9901958A3 (en) 2000-04-28
BR9708443B1 (en) 2012-06-12
CA2248182A1 (en) 1997-09-04
MX9807083A (en) 1998-12-31
CN1165342C (en) 2004-09-08
KR19990087432A (en) 1999-12-27
AU2277497A (en) 1997-09-16
WO1997031651A1 (en) 1997-09-04
CO4600644A1 (en) 1998-05-08
BR9708443A (en) 1999-08-03
EE9800267A (en) 1999-02-15
SK119498A3 (en) 1999-07-12
CA2248182C (en) 2004-04-20
EP0894007A1 (en) 1999-02-03
BG64693B1 (en) 2005-12-30

Similar Documents

Publication Publication Date Title
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
GB9418775D0 (en) Vaccine for the preventoin of porcine reproductive and respiratory syndrome
AU3699197A (en) Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
EP0642802A3 (en) Inhalation device.
HUP9801570A3 (en) Polysiloxane-comprising perfluoroalkyl ethers, and the preparation and use thereof
EP0655256A3 (en) Inhaler.
ZA975889B (en) HIV envelope polypeptides and vaccine.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
ZA987092B (en) Inhalation device.
MXPA00004635A (en) Inhalation device.
ZA982019B (en) Inhalation device.
AU133903S (en) Inhaler device
PL332633A1 (en) Vaccines
ZA919797B (en) Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones
HU9602421D0 (en) Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
EP0958373A4 (en) Vaccines
KR100267806B1 (en) Reflection type mask structure and explosure apparatus using the same
EP0738144A4 (en) Phenylmethyl hexanamides, and the use thereof
EP0677787A3 (en) Mask and mask supporting mechanism.
ZA9711047B (en) Formulation and use.
GB9618890D0 (en) An immunogenic determinant
ZA9610510B (en) Novel peptides, the preparation and use thereof.
EP0759778A4 (en) Non-infective vaccines
ZA972059B (en) Components for inhalation devices.